Clesrovimab is an extended half-life RSV neutralizing antibody in development for all infants in their first RSV season and ...

"Inebilizumab is a humanized monoclonal antibody that causes targeted and sustained depletion of CD19-positive B cells, ...

The investigational monoclonal antibody nipocalimab is associated with significant improvement in patients with generalized ...

An interim analysis from a long-term open-label extension study has underlined the clinical efficacy and safety of ...

Image Credit: Nemes Laszlo/Shutterstock.com Contact stirring, however, demonstrates just one type of stress that can occur ...

Figure 2 depicts the impact of pH on monoclonal antibody stability. When subjected to the same temperature and mechanical stress conditions, changes in pH significantly disrupted stability with ...

A study led by Dr. Hassan Aboul-Ella (Department of Microbiology, Faculty of Veterinary Medicine, Cairo University) has been ...

Clesrovimab (MK-1654), an Investigational RSV Monoclonal Antibody, Significantly Reduced Incidence of RSV Disease and ...

Explore how mAbs are transforming disease treatment, the evolution from murine to humanized antibodies, and the impact of biosimilar antibodies on cost-effective therapies.

FRIDAY, Oct. 4, 2024 (HealthDay News) -- Tulisokibart, a tumor necrosis factor-like cytokine 1A monoclonal antibody, is more ...

Merck, known as MSD outside of the United States and Canada, announced the presentation of positive results from the phase 2b/3 clinical trial (MK-1654-004) evaluating clesrovimab, the company’s ...